Guerbet

This study looked at the safety of using a special dye (Lipiodol) mixed with surgical glue to block abnormal blood vessels in 132 adults with conditions like hemangiomas or arteriovenous malformations. The procedure aimed to control disease by cutting off blood flow to the proble…

This study tested a new contrast agent called Elucirem (gadopiclenol) for MRI scans of brain gliomas. It involved 138 adults with new or returning brain tumors. The goal was to see if Elucirem produced clearer images than the standard contrast agent, Dotarem, when measuring blood…

This study tested a new contrast agent called gadopiclenol to see if it makes brain lesions show up better on MRI scans. 260 adults with known or suspected brain lesions received an MRI with and without the agent. Results showed that gadopiclenol improved the visibility of lesion…

This study tested a new contrast agent called gadopiclenol to see if it makes body MRI scans clearer. 324 adults with known or suspected lesions in their body took part. The goal was to see if the enhanced scans helped doctors see lesion borders, internal details, and contrast be…

This study looked at how the contrast agent gadopiclenol behaves in the bodies of 36 infants and toddlers up to 23 months old who needed an MRI. Researchers measured drug levels and how quickly it left the body to understand safety and dosing. The goal was to gather information, …